‘NRG-GY006: A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer’ of page ‘NRG-GY006’
Principal Investigator/Co-Principal Investigator Charles Leath, MD/Charles Kunos, MD, Ph.D Primary Objective To evaluate the efficacy of the experimental regimen of triapine (3AP), cisplatin, and radiation to increase progression-free survival relative to the standard / control regimen of cisplatin and radiation in women with uterine cervix and vaginal cancer. Hypothesis: The experimental regimen, triapine (3AP) in […]
Read More